DEVICE · Unmapped registry intervention
Ice-Sense3TM/ ProSenseTM
Find medicine records ·
Find other trials using this name
Clinical trial
Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial
NCT02200705
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedCryoablation of Low Risk Small Breast Cancer- ICE3 Trial
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Ice-Sense3TM/ ProSenseTMDEVICE
Sponsors & collaborators
IceCure Medical Ltd.lead sponsor
Mapped research locations
New YorkNew York, United States4PhiladelphiaPennsylvania, United States1ClevelandOhio, United States1CincinnatiOhio, United States1IndianapolisIndiana, United States1DetroitMichigan, United States1AlbuquerqueNew Mexico, United States1FlintMichigan, United States1Santa AnaCalifornia, United States1PlanoTexas, United States1TroyMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02200705 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.